XML 35 R6.htm IDEA: XBRL DOCUMENT v3.3.0.814
Statements of Cash Flows - USD ($)
3 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Cash flows from operating activities    
Net loss $ (2,276,188) $ (2,105,061)
Stock-based compensation expense 68,322 202,011
Depreciation, amortization and accretion 128,921 24,582
Amortization of prepaid research and development - related party (Note 11) 30,496 30,496
Deferred taxes 0 (23,909)
Adjustments to reconcile net loss to net cash used in operating activities:    
(Increase) in accounts receivable (10,872)  
(Increase) in inventory (454,638)  
Decrease in prepaid expenses, other 10,357 515,107
(Increase) in prepaid research and development - related party (Note 11) 0 (150,000)
(Decrease) in accounts payable and accrued liabilities 0 (136,188)
Increase in interest payable to Ampio   37,375
Increase in accrued compensation 420,538  
(Decrease) in payable to Ampio 0 (561,059)
Increase in interest payable 57,637  
Increase in deferred rent 11,379  
(Decrease) in deferred revenue (21,428) (21,429)
Net cash used in operating activities (2,157,160) (2,188,075)
Cash flows used in investing activities    
Purchases of property and equipment (3,554)  
Net cash used in investing activities (3,554)  
Cash flows from financing activities    
Proceeds from convertible promissory notes (Note 8) 5,175,000  
Debt issuance costs (Note 8) (298,322)  
Contribution from Ampio 0 600,000
Net cash provided by financing activities 4,876,678 600,000
Net change in cash and cash equivalents 2,715,964 (1,588,075)
Cash and cash equivalents at beginning of period 7,353,061 2,639,650
Cash and cash equivalents at end of period 10,069,025 $ 1,051,575
Non-cash transactions:    
Warrant derivative liability (Note 8) $ 102,931